federal_register: 2016-29303

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2016-29303 Determination of Regulatory Review Period for Purposes of Patent Extension; GARDASIL 9 Notice The Food and Drug Administration (FDA) has determined the regulatory review period for GARDASIL 9 and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product. 2016-12-07 2016 12 https://www.federalregister.gov/documents/2016/12/07/2016-29303/determination-of-regulatory-review-period-for-purposes-of-patent-extension-gardasil-9 https://www.govinfo.gov/content/pkg/FR-2016-12-07/pdf/2016-29303.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) has determined the regulatory review period for GARDASIL 9 and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the...

Links from other tables